Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Spero

Trust us - you want to have this affordable jewellery brand on your radar

Sustainable handmade jewellery at sub-£100 prices? Yes please.

Marie Claire · Apr 25, 2024

Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.

Benzinga · Sep 22, 2022

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and…

Benzinga · May 31, 2022

FDA Identifies Review Issues For Spero's Tebipenem Application, Shares Plunge

Spero Therapeutics Inc (NASDAQ:SPRO) will defer current commercialization activities for tebipenem HBr based on feedback from a recent Late Cycle Meeting (LCM) with the FDA. The discussion suggested that the data package may be insufficient to support approval during this review cycle. In evaluating the efficacy of tebipenem HBr in Phase 3 (ADAPT-PO)…

Benzinga · May 3, 2022

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · May 3, 2022

Coverage From

Organisations

Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Disease

16,766 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

421,281 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.